Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Notes Payables (2016 - 2022)

Nutex Health's Notes Payables history spans 8 years, with the latest figure at $553150.0 for Q1 2022.

  • For Q1 2022, Notes Payables fell 32.95% year-over-year to $553150.0; the TTM value through Mar 2022 reached $553150.0, down 32.95%, while the annual FY2021 figure was $1960.0, 94.93% down from the prior year.
  • Notes Payables for Q1 2022 was $553150.0 at Nutex Health, up from $1960.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $2.2 million in Q1 2020 and bottomed at $1960.0 in Q4 2021.
  • The 5-year median for Notes Payables is $445593.0 (2019), against an average of $577607.6.
  • The largest YoY upside for Notes Payables was 4111.35% in 2020 against a maximum downside of 98.17% in 2020.
  • A 5-year view of Notes Payables shows it stood at $177055.0 in 2018, then soared by 1092.88% to $2.1 million in 2019, then plummeted by 98.17% to $38651.0 in 2020, then crashed by 94.93% to $1960.0 in 2021, then surged by 28121.94% to $553150.0 in 2022.
  • Per Business Quant, the three most recent readings for NUTX's Notes Payables are $553150.0 (Q1 2022), $1960.0 (Q4 2021), and $813127.0 (Q3 2021).